nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.103	0.155	CbGbCtD
Nateglinide—CYP3A7—Progesterone—uterine cancer	0.103	0.155	CbGbCtD
Nateglinide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0781	0.118	CbGbCtD
Nateglinide—CYP3A5—Progesterone—uterine cancer	0.0772	0.116	CbGbCtD
Nateglinide—PTGS1—Etoposide—uterine cancer	0.0575	0.0865	CbGbCtD
Nateglinide—CYP2C9—Progesterone—uterine cancer	0.0517	0.0778	CbGbCtD
Nateglinide—CYP2D6—Progesterone—uterine cancer	0.0473	0.0712	CbGbCtD
Nateglinide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0454	0.0683	CbGbCtD
Nateglinide—CYP3A5—Etoposide—uterine cancer	0.0345	0.0519	CbGbCtD
Nateglinide—CYP3A4—Progesterone—uterine cancer	0.0301	0.0453	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—uterine cancer	0.0144	0.0217	CbGbCtD
Nateglinide—CYP3A4—Etoposide—uterine cancer	0.0135	0.0203	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—uterine cancer	0.00918	0.0138	CbGbCtD
Nateglinide—Hepatitis cholestatic—Progesterone—uterine cancer	0.00759	0.0547	CcSEcCtD
Nateglinide—PPARG—artery—uterine cancer	0.00439	0.0483	CbGeAlD
Nateglinide—PPARG—Teniposide—Etoposide—uterine cancer	0.0042	1	CbGdCrCtD
Nateglinide—PTGS1—oviduct—uterine cancer	0.00355	0.039	CbGeAlD
Nateglinide—Hepatic enzyme increased—Progesterone—uterine cancer	0.00323	0.0233	CcSEcCtD
Nateglinide—UGT1A9—renal system—uterine cancer	0.00314	0.0345	CbGeAlD
Nateglinide—Injury—Progesterone—uterine cancer	0.00241	0.0174	CcSEcCtD
Nateglinide—Increased appetite—Progesterone—uterine cancer	0.00236	0.017	CcSEcCtD
Nateglinide—PTGS1—artery—uterine cancer	0.00235	0.0258	CbGeAlD
Nateglinide—Thirst—Progesterone—uterine cancer	0.00233	0.0168	CcSEcCtD
Nateglinide—Osteoarthritis—Progesterone—uterine cancer	0.00222	0.016	CcSEcCtD
Nateglinide—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.0154	CcSEcCtD
Nateglinide—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.0152	CcSEcCtD
Nateglinide—ABCC8—smooth muscle tissue—uterine cancer	0.0021	0.0231	CbGeAlD
Nateglinide—SLC15A1—epithelium—uterine cancer	0.00209	0.0229	CbGeAlD
Nateglinide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.0149	CcSEcCtD
Nateglinide—ABCC8—renal system—uterine cancer	0.00202	0.0223	CbGeAlD
Nateglinide—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.0145	CcSEcCtD
Nateglinide—SLC16A1—epithelium—uterine cancer	0.00198	0.0218	CbGeAlD
Nateglinide—ABCC8—endometrium—uterine cancer	0.00196	0.0215	CbGeAlD
Nateglinide—SLC15A1—renal system—uterine cancer	0.00193	0.0213	CbGeAlD
Nateglinide—SLC16A1—decidua—uterine cancer	0.00188	0.0206	CbGeAlD
Nateglinide—SLC15A1—endometrium—uterine cancer	0.00187	0.0206	CbGeAlD
Nateglinide—Sweating increased—Progesterone—uterine cancer	0.00187	0.0135	CcSEcCtD
Nateglinide—Bronchitis—Progesterone—uterine cancer	0.00184	0.0133	CcSEcCtD
Nateglinide—SLC16A1—renal system—uterine cancer	0.00184	0.0202	CbGeAlD
Nateglinide—SLC15A1—mammalian vulva—uterine cancer	0.00181	0.0199	CbGeAlD
Nateglinide—Upper respiratory tract infection—Progesterone—uterine cancer	0.00178	0.0128	CcSEcCtD
Nateglinide—SLC16A1—endometrium—uterine cancer	0.00178	0.0196	CbGeAlD
Nateglinide—KCNJ11—female reproductive system—uterine cancer	0.00176	0.0193	CbGeAlD
Nateglinide—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.0125	CcSEcCtD
Nateglinide—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.0122	CcSEcCtD
Nateglinide—Neuropathy peripheral—Progesterone—uterine cancer	0.00168	0.0121	CcSEcCtD
Nateglinide—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.012	CcSEcCtD
Nateglinide—Jaundice—Progesterone—uterine cancer	0.00167	0.012	CcSEcCtD
Nateglinide—PPARG—epithelium—uterine cancer	0.00167	0.0183	CbGeAlD
Nateglinide—SLC16A1—uterus—uterine cancer	0.00164	0.018	CbGeAlD
Nateglinide—Hepatobiliary disease—Progesterone—uterine cancer	0.00162	0.0117	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0116	CcSEcCtD
Nateglinide—PPARG—smooth muscle tissue—uterine cancer	0.0016	0.0176	CbGeAlD
Nateglinide—KCNJ11—female gonad—uterine cancer	0.0016	0.0176	CbGeAlD
Nateglinide—ORM1—endometrium—uterine cancer	0.0016	0.0176	CbGeAlD
Nateglinide—PPARG—decidua—uterine cancer	0.00157	0.0173	CbGeAlD
Nateglinide—PPARG—renal system—uterine cancer	0.00154	0.017	CbGeAlD
Nateglinide—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.0109	CcSEcCtD
Nateglinide—Oedema peripheral—Progesterone—uterine cancer	0.00151	0.0109	CcSEcCtD
Nateglinide—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.0109	CcSEcCtD
Nateglinide—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0107	CcSEcCtD
Nateglinide—SLC16A1—female reproductive system—uterine cancer	0.00147	0.0162	CbGeAlD
Nateglinide—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0106	CcSEcCtD
Nateglinide—Erythema multiforme—Progesterone—uterine cancer	0.00145	0.0105	CcSEcCtD
Nateglinide—PPARG—mammalian vulva—uterine cancer	0.00144	0.0159	CbGeAlD
Nateglinide—ABCC4—renal system—uterine cancer	0.0014	0.0154	CbGeAlD
Nateglinide—SLC15A1—vagina—uterine cancer	0.0014	0.0154	CbGeAlD
Nateglinide—Immune system disorder—Progesterone—uterine cancer	0.00139	0.01	CcSEcCtD
Nateglinide—PPARG—uterus—uterine cancer	0.00138	0.0151	CbGeAlD
Nateglinide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00988	CcSEcCtD
Nateglinide—SLC16A1—female gonad—uterine cancer	0.00134	0.0148	CbGeAlD
Nateglinide—Malnutrition—Progesterone—uterine cancer	0.00134	0.00963	CcSEcCtD
Nateglinide—ORM1—female reproductive system—uterine cancer	0.00132	0.0146	CbGeAlD
Nateglinide—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00948	CcSEcCtD
Nateglinide—SLC15A2—uterine cervix—uterine cancer	0.00129	0.0142	CbGeAlD
Nateglinide—Back pain—Progesterone—uterine cancer	0.00129	0.00932	CcSEcCtD
Nateglinide—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00906	CcSEcCtD
Nateglinide—Tremor—Progesterone—uterine cancer	0.00125	0.00903	CcSEcCtD
Nateglinide—ABCC4—uterus—uterine cancer	0.00125	0.0137	CbGeAlD
Nateglinide—PPARG—female reproductive system—uterine cancer	0.00124	0.0136	CbGeAlD
Nateglinide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00873	CcSEcCtD
Nateglinide—SLC15A2—renal system—uterine cancer	0.00121	0.0133	CbGeAlD
Nateglinide—Palpitations—Progesterone—uterine cancer	0.00118	0.00851	CcSEcCtD
Nateglinide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00844	CcSEcCtD
Nateglinide—SLC15A2—endometrium—uterine cancer	0.00117	0.0129	CbGeAlD
Nateglinide—Cough—Progesterone—uterine cancer	0.00117	0.00841	CcSEcCtD
Nateglinide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00818	CcSEcCtD
Nateglinide—PPARG—female gonad—uterine cancer	0.00113	0.0124	CbGeAlD
Nateglinide—ABCC4—female reproductive system—uterine cancer	0.00112	0.0124	CbGeAlD
Nateglinide—PPARG—vagina—uterine cancer	0.00112	0.0123	CbGeAlD
Nateglinide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00771	CcSEcCtD
Nateglinide—Hyperhidrosis—Progesterone—uterine cancer	0.00105	0.0076	CcSEcCtD
Nateglinide—KCNJ11—lymph node—uterine cancer	0.00103	0.0113	CbGeAlD
Nateglinide—Erythema multiforme—Dactinomycin—uterine cancer	0.00103	0.0074	CcSEcCtD
Nateglinide—ABCC4—female gonad—uterine cancer	0.00102	0.0112	CbGeAlD
Nateglinide—CYP3A5—uterine cervix—uterine cancer	0.000982	0.0108	CbGeAlD
Nateglinide—SLC15A2—female reproductive system—uterine cancer	0.000969	0.0107	CbGeAlD
Nateglinide—Arthropathy—Epirubicin—uterine cancer	0.000964	0.00695	CcSEcCtD
Nateglinide—Dyspepsia—Progesterone—uterine cancer	0.00096	0.00692	CcSEcCtD
Nateglinide—Sweating increased—Etoposide—uterine cancer	0.000956	0.00689	CcSEcCtD
Nateglinide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000955	0.00689	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000942	0.00679	CcSEcCtD
Nateglinide—Fatigue—Progesterone—uterine cancer	0.00094	0.00678	CcSEcCtD
Nateglinide—CYP3A5—renal system—uterine cancer	0.000919	0.0101	CbGeAlD
Nateglinide—Arthropathy—Doxorubicin—uterine cancer	0.000892	0.00643	CcSEcCtD
Nateglinide—Gastrointestinal pain—Progesterone—uterine cancer	0.000892	0.00643	CcSEcCtD
Nateglinide—PTGS1—epithelium—uterine cancer	0.00089	0.00979	CbGeAlD
Nateglinide—PTGS1—uterine cervix—uterine cancer	0.000883	0.00971	CbGeAlD
Nateglinide—SLC15A2—female gonad—uterine cancer	0.000881	0.00969	CbGeAlD
Nateglinide—SLC15A2—vagina—uterine cancer	0.000876	0.00963	CbGeAlD
Nateglinide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00087	0.00627	CcSEcCtD
Nateglinide—Urticaria—Progesterone—uterine cancer	0.000866	0.00625	CcSEcCtD
Nateglinide—SLC16A1—lymph node—uterine cancer	0.000863	0.00949	CbGeAlD
Nateglinide—Abdominal pain—Progesterone—uterine cancer	0.000862	0.00621	CcSEcCtD
Nateglinide—PTGS1—smooth muscle tissue—uterine cancer	0.000858	0.00943	CbGeAlD
Nateglinide—Neuropathy peripheral—Etoposide—uterine cancer	0.000858	0.00618	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00615	CcSEcCtD
Nateglinide—Jaundice—Etoposide—uterine cancer	0.000853	0.00615	CcSEcCtD
Nateglinide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000852	0.00614	CcSEcCtD
Nateglinide—Hepatobiliary disease—Etoposide—uterine cancer	0.000827	0.00596	CcSEcCtD
Nateglinide—PTGS1—renal system—uterine cancer	0.000826	0.00908	CbGeAlD
Nateglinide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00583	CcSEcCtD
Nateglinide—Hypersensitivity—Progesterone—uterine cancer	0.000804	0.00579	CcSEcCtD
Nateglinide—PTGS1—endometrium—uterine cancer	0.000798	0.00878	CbGeAlD
Nateglinide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.00566	CcSEcCtD
Nateglinide—Asthenia—Progesterone—uterine cancer	0.000783	0.00564	CcSEcCtD
Nateglinide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.00563	CcSEcCtD
Nateglinide—ORM1—lymph node—uterine cancer	0.000774	0.00851	CbGeAlD
Nateglinide—PTGS1—mammalian vulva—uterine cancer	0.000772	0.00849	CbGeAlD
Nateglinide—Pruritus—Progesterone—uterine cancer	0.000772	0.00556	CcSEcCtD
Nateglinide—Diarrhoea—Progesterone—uterine cancer	0.000746	0.00538	CcSEcCtD
Nateglinide—Erythema multiforme—Etoposide—uterine cancer	0.000743	0.00535	CcSEcCtD
Nateglinide—PTGS1—uterus—uterine cancer	0.000736	0.00809	CbGeAlD
Nateglinide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00525	CcSEcCtD
Nateglinide—CYP2C9—female reproductive system—uterine cancer	0.000724	0.00797	CbGeAlD
Nateglinide—PPARG—lymph node—uterine cancer	0.000724	0.00796	CbGeAlD
Nateglinide—Dizziness—Progesterone—uterine cancer	0.000721	0.0052	CcSEcCtD
Nateglinide—Immune system disorder—Etoposide—uterine cancer	0.000709	0.00511	CcSEcCtD
Nateglinide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000709	0.00511	CcSEcCtD
Nateglinide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.00504	CcSEcCtD
Nateglinide—Vomiting—Progesterone—uterine cancer	0.000693	0.005	CcSEcCtD
Nateglinide—CYP3A4—renal system—uterine cancer	0.00069	0.00759	CbGeAlD
Nateglinide—Rash—Progesterone—uterine cancer	0.000688	0.00496	CcSEcCtD
Nateglinide—Dermatitis—Progesterone—uterine cancer	0.000687	0.00495	CcSEcCtD
Nateglinide—ALB—lymph node—uterine cancer	0.000679	0.00747	CbGeAlD
Nateglinide—CYP2D6—renal system—uterine cancer	0.000679	0.00746	CbGeAlD
Nateglinide—Increased appetite—Epirubicin—uterine cancer	0.000677	0.00488	CcSEcCtD
Nateglinide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000676	0.00487	CcSEcCtD
Nateglinide—CYP3A5—female gonad—uterine cancer	0.00067	0.00737	CbGeAlD
Nateglinide—CYP3A5—vagina—uterine cancer	0.000666	0.00732	CbGeAlD
Nateglinide—Fatigue—Dactinomycin—uterine cancer	0.000665	0.00479	CcSEcCtD
Nateglinide—PTGS1—female reproductive system—uterine cancer	0.000661	0.00727	CbGeAlD
Nateglinide—Back pain—Etoposide—uterine cancer	0.000661	0.00477	CcSEcCtD
Nateglinide—ABCC4—lymph node—uterine cancer	0.000657	0.00723	CbGeAlD
Nateglinide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000654	0.00471	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—uterine cancer	0.000652	0.0047	CcSEcCtD
Nateglinide—Nausea—Progesterone—uterine cancer	0.000648	0.00467	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—uterine cancer	0.000636	0.00459	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00063	0.00454	CcSEcCtD
Nateglinide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000628	0.00453	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—uterine cancer	0.000627	0.00452	CcSEcCtD
Nateglinide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000623	0.00449	CcSEcCtD
Nateglinide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000623	0.00449	CcSEcCtD
Nateglinide—Abdominal pain—Dactinomycin—uterine cancer	0.000609	0.00439	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000603	0.00435	CcSEcCtD
Nateglinide—PTGS1—female gonad—uterine cancer	0.000602	0.00662	CbGeAlD
Nateglinide—PTGS1—vagina—uterine cancer	0.000598	0.00658	CbGeAlD
Nateglinide—Cough—Etoposide—uterine cancer	0.000597	0.0043	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—uterine cancer	0.000589	0.00424	CcSEcCtD
Nateglinide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00423	CcSEcCtD
Nateglinide—Hypersensitivity—Dactinomycin—uterine cancer	0.000568	0.00409	CcSEcCtD
Nateglinide—SLC15A2—lymph node—uterine cancer	0.000567	0.00623	CbGeAlD
Nateglinide—Asthenia—Dactinomycin—uterine cancer	0.000553	0.00399	CcSEcCtD
Nateglinide—CYP3A4—female reproductive system—uterine cancer	0.000552	0.00608	CbGeAlD
Nateglinide—Influenza—Epirubicin—uterine cancer	0.00055	0.00396	CcSEcCtD
Nateglinide—CYP2D6—female reproductive system—uterine cancer	0.000544	0.00598	CbGeAlD
Nateglinide—Hyperhidrosis—Etoposide—uterine cancer	0.000539	0.00389	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—uterine cancer	0.000529	0.00381	CcSEcCtD
Nateglinide—Diarrhoea—Dactinomycin—uterine cancer	0.000527	0.0038	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000511	0.00368	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—uterine cancer	0.000509	0.00367	CcSEcCtD
Nateglinide—CYP2D6—female gonad—uterine cancer	0.000495	0.00544	CbGeAlD
Nateglinide—Vomiting—Dactinomycin—uterine cancer	0.00049	0.00353	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—uterine cancer	0.000489	0.00353	CcSEcCtD
Nateglinide—Rash—Dactinomycin—uterine cancer	0.000486	0.0035	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000482	0.00347	CcSEcCtD
Nateglinide—Fatigue—Etoposide—uterine cancer	0.000481	0.00347	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—uterine cancer	0.000481	0.00346	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—uterine cancer	0.000478	0.00345	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000473	0.00341	CcSEcCtD
Nateglinide—Sweating—Epirubicin—uterine cancer	0.00047	0.00339	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000464	0.00334	CcSEcCtD
Nateglinide—Nausea—Dactinomycin—uterine cancer	0.000458	0.0033	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—uterine cancer	0.000456	0.00329	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000445	0.00321	CcSEcCtD
Nateglinide—Urticaria—Etoposide—uterine cancer	0.000443	0.00319	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—uterine cancer	0.000442	0.00319	CcSEcCtD
Nateglinide—Abdominal pain—Etoposide—uterine cancer	0.000441	0.00318	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—uterine cancer	0.000435	0.00314	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—uterine cancer	0.000434	0.00313	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000429	0.00309	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—uterine cancer	0.000416	0.003	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—uterine cancer	0.000411	0.00296	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—uterine cancer	0.000401	0.00289	CcSEcCtD
Nateglinide—Asthenia—Etoposide—uterine cancer	0.0004	0.00289	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—uterine cancer	0.000398	0.00287	CcSEcCtD
Nateglinide—Pruritus—Etoposide—uterine cancer	0.000395	0.00285	CcSEcCtD
Nateglinide—PTGS1—lymph node—uterine cancer	0.000387	0.00425	CbGeAlD
Nateglinide—Erythema multiforme—Doxorubicin—uterine cancer	0.000385	0.00278	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—uterine cancer	0.000383	0.00276	CcSEcCtD
Nateglinide—Diarrhoea—Etoposide—uterine cancer	0.000382	0.00275	CcSEcCtD
Nateglinide—Back pain—Epirubicin—uterine cancer	0.000371	0.00267	CcSEcCtD
Nateglinide—Dizziness—Etoposide—uterine cancer	0.000369	0.00266	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—uterine cancer	0.000368	0.00265	CcSEcCtD
Nateglinide—Vomiting—Etoposide—uterine cancer	0.000355	0.00256	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—uterine cancer	0.000355	0.00256	CcSEcCtD
Nateglinide—Rash—Etoposide—uterine cancer	0.000352	0.00254	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—uterine cancer	0.000351	0.00253	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—uterine cancer	0.000343	0.00247	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—uterine cancer	0.000339	0.00244	CcSEcCtD
Nateglinide—Cough—Epirubicin—uterine cancer	0.000334	0.00241	CcSEcCtD
Nateglinide—Nausea—Etoposide—uterine cancer	0.000331	0.00239	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—uterine cancer	0.000313	0.00226	CcSEcCtD
Nateglinide—Cough—Doxorubicin—uterine cancer	0.000309	0.00223	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—uterine cancer	0.000302	0.00218	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—uterine cancer	0.00028	0.00202	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—uterine cancer	0.000275	0.00198	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00027	0.00195	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—uterine cancer	0.00027	0.00194	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000256	0.00184	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—uterine cancer	0.000255	0.00184	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00025	0.0018	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—uterine cancer	0.00025	0.0018	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—uterine cancer	0.000248	0.00179	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—uterine cancer	0.000247	0.00178	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000237	0.00171	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—uterine cancer	0.00023	0.00166	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—uterine cancer	0.00023	0.00166	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—uterine cancer	0.000229	0.00165	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—uterine cancer	0.000224	0.00162	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—uterine cancer	0.000221	0.00159	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—uterine cancer	0.000214	0.00154	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—uterine cancer	0.000213	0.00154	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—uterine cancer	0.000208	0.0015	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—uterine cancer	0.000207	0.00149	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—uterine cancer	0.000205	0.00148	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—uterine cancer	0.000199	0.00143	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—uterine cancer	0.000198	0.00143	CcSEcCtD
Nateglinide—Rash—Epirubicin—uterine cancer	0.000197	0.00142	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—uterine cancer	0.000197	0.00142	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—uterine cancer	0.000191	0.00138	CcSEcCtD
Nateglinide—Nausea—Epirubicin—uterine cancer	0.000186	0.00134	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—uterine cancer	0.000184	0.00133	CcSEcCtD
Nateglinide—Rash—Doxorubicin—uterine cancer	0.000182	0.00132	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—uterine cancer	0.000182	0.00131	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—uterine cancer	0.000172	0.00124	CcSEcCtD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.94e-05	0.000684	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.94e-05	0.000684	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP11A1—uterine cancer	6.8e-05	0.00067	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—uterine cancer	6.77e-05	0.000668	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP11A1—uterine cancer	6.7e-05	0.00066	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	6.64e-05	0.000655	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	6.64e-05	0.000654	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKR1C3—uterine cancer	6.62e-05	0.000653	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	6.59e-05	0.00065	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—POLD1—uterine cancer	6.59e-05	0.000649	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	6.45e-05	0.000636	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKR1C3—uterine cancer	6.42e-05	0.000633	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKR1C3—uterine cancer	6.32e-05	0.000624	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MET—uterine cancer	6.23e-05	0.000614	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.22e-05	0.000614	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKR1C1—uterine cancer	6.16e-05	0.000607	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKR1B1—uterine cancer	6.07e-05	0.000598	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—STAR—uterine cancer	6.07e-05	0.000598	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SRD5A2—uterine cancer	6.07e-05	0.000598	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NDUFB11—uterine cancer	6.07e-05	0.000598	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—uterine cancer	5.97e-05	0.000588	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—PGR—uterine cancer	5.94e-05	0.000586	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKR1B1—uterine cancer	5.88e-05	0.00058	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—STAR—uterine cancer	5.88e-05	0.00058	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.81e-05	0.000573	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POLD1—uterine cancer	5.66e-05	0.000558	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—EZH2—uterine cancer	5.65e-05	0.000557	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—HRAS—uterine cancer	5.59e-05	0.000551	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—RRM2—uterine cancer	5.49e-05	0.000541	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—uterine cancer	5.44e-05	0.000537	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—HRAS—uterine cancer	5.42e-05	0.000534	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—DCN—uterine cancer	5.33e-05	0.000526	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKR1C1—uterine cancer	5.29e-05	0.000522	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	5.25e-05	0.000517	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IRF1—uterine cancer	5.24e-05	0.000516	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ESR2—uterine cancer	5.23e-05	0.000516	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SRD5A2—uterine cancer	5.22e-05	0.000515	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NDUFB11—uterine cancer	5.22e-05	0.000515	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.18e-05	0.000511	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.18e-05	0.00051	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—STK11—uterine cancer	5.16e-05	0.000508	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP19A1—uterine cancer	5.16e-05	0.000508	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.09e-05	0.000502	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.07e-05	0.0005	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP11A1—uterine cancer	5.02e-05	0.000495	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP19A1—uterine cancer	5e-05	0.000493	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—STK11—uterine cancer	5e-05	0.000493	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—STK11—uterine cancer	4.93e-05	0.000486	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP19A1—uterine cancer	4.93e-05	0.000486	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—EP300—uterine cancer	4.85e-05	0.000478	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.79e-05	0.000472	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POLD1—uterine cancer	4.76e-05	0.000469	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKR1C3—uterine cancer	4.74e-05	0.000468	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—RRM2—uterine cancer	4.72e-05	0.000465	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POLD1—uterine cancer	4.61e-05	0.000455	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—uterine cancer	4.59e-05	0.000452	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—DCN—uterine cancer	4.58e-05	0.000452	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—ERBB2—uterine cancer	4.55e-05	0.000449	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NRAS—uterine cancer	4.53e-05	0.000447	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKR1C1—uterine cancer	4.45e-05	0.000439	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1B1—uterine cancer	4.39e-05	0.000432	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—STAR—uterine cancer	4.39e-05	0.000432	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKR1C1—uterine cancer	4.32e-05	0.000426	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP11A1—uterine cancer	4.32e-05	0.000426	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SRD5A2—uterine cancer	4.31e-05	0.000425	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NDUFB11—uterine cancer	4.31e-05	0.000425	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NDUFB11—uterine cancer	4.28e-05	0.000422	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SRD5A2—uterine cancer	4.28e-05	0.000422	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—CDKN2B—uterine cancer	4.26e-05	0.00042	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.24e-05	0.000418	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.15e-05	0.000409	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKR1C3—uterine cancer	4.08e-05	0.000402	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CTNNB1—uterine cancer	3.98e-05	0.000393	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—RRM2—uterine cancer	3.97e-05	0.000391	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.92e-05	0.000387	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—KRAS—uterine cancer	3.9e-05	0.000385	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SMAD3—uterine cancer	3.89e-05	0.000383	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—MTHFR—uterine cancer	3.87e-05	0.000382	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—DCN—uterine cancer	3.85e-05	0.00038	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—RRM2—uterine cancer	3.85e-05	0.000379	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1B1—uterine cancer	3.78e-05	0.000372	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STAR—uterine cancer	3.78e-05	0.000372	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—MTHFR—uterine cancer	3.76e-05	0.00037	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—DCN—uterine cancer	3.73e-05	0.000368	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.73e-05	0.000368	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EP300—uterine cancer	3.7e-05	0.000365	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—MTHFR—uterine cancer	3.7e-05	0.000365	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—STK11—uterine cancer	3.7e-05	0.000364	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP19A1—uterine cancer	3.7e-05	0.000364	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP11A1—uterine cancer	3.63e-05	0.000358	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—EP300—uterine cancer	3.61e-05	0.000356	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PIK3CA—uterine cancer	3.58e-05	0.000353	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP11A1—uterine cancer	3.52e-05	0.000347	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—uterine cancer	3.51e-05	0.000346	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.47e-05	0.000342	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—uterine cancer	3.47e-05	0.000342	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NRAS—uterine cancer	3.46e-05	0.000342	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POLD1—uterine cancer	3.44e-05	0.000339	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKR1C3—uterine cancer	3.43e-05	0.000338	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—uterine cancer	3.42e-05	0.000337	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NRAS—uterine cancer	3.38e-05	0.000333	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKR1C3—uterine cancer	3.32e-05	0.000328	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—uterine cancer	3.32e-05	0.000327	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.31e-05	0.000326	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1C1—uterine cancer	3.22e-05	0.000317	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP19A1—uterine cancer	3.18e-05	0.000313	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—STK11—uterine cancer	3.18e-05	0.000313	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ESR1—uterine cancer	3.17e-05	0.000313	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1B1—uterine cancer	3.12e-05	0.000307	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STAR—uterine cancer	3.12e-05	0.000307	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STAR—uterine cancer	3.09e-05	0.000305	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.09e-05	0.000305	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.06e-05	0.000301	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3e-05	0.000296	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—uterine cancer	2.98e-05	0.000294	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.98e-05	0.000294	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POLD1—uterine cancer	2.96e-05	0.000292	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—uterine cancer	2.93e-05	0.000289	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—uterine cancer	2.91e-05	0.000287	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—RRM2—uterine cancer	2.87e-05	0.000283	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.84e-05	0.00028	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.82e-05	0.000278	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.82e-05	0.000278	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DCN—uterine cancer	2.78e-05	0.000275	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTHFR—uterine cancer	2.78e-05	0.000274	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1C1—uterine cancer	2.77e-05	0.000273	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—uterine cancer	2.67e-05	0.000263	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP19A1—uterine cancer	2.67e-05	0.000263	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—STK11—uterine cancer	2.67e-05	0.000263	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.62e-05	0.000259	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—STK11—uterine cancer	2.59e-05	0.000255	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP19A1—uterine cancer	2.59e-05	0.000255	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—uterine cancer	2.59e-05	0.000255	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—uterine cancer	2.53e-05	0.00025	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.48e-05	0.000244	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—uterine cancer	2.47e-05	0.000244	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RRM2—uterine cancer	2.47e-05	0.000244	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.45e-05	0.000241	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POLD1—uterine cancer	2.45e-05	0.000241	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.43e-05	0.00024	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POLD1—uterine cancer	2.43e-05	0.000239	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DCN—uterine cancer	2.4e-05	0.000236	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—uterine cancer	2.39e-05	0.000235	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.35e-05	0.000231	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.32e-05	0.000228	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.29e-05	0.000226	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.27e-05	0.000224	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP11A1—uterine cancer	2.26e-05	0.000223	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—uterine cancer	2.24e-05	0.000221	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—uterine cancer	2.18e-05	0.000215	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTEN—uterine cancer	2.16e-05	0.000213	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1C3—uterine cancer	2.13e-05	0.00021	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.1e-05	0.000207	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTEN—uterine cancer	2.09e-05	0.000206	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—uterine cancer	2.06e-05	0.000203	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—EP300—uterine cancer	2.06e-05	0.000203	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RRM2—uterine cancer	2.04e-05	0.000201	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STAR—uterine cancer	2.04e-05	0.000201	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.04e-05	0.000201	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RRM2—uterine cancer	2.02e-05	0.000199	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—uterine cancer	2.01e-05	0.000198	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—EP300—uterine cancer	1.99e-05	0.000197	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DCN—uterine cancer	1.98e-05	0.000195	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—EP300—uterine cancer	1.96e-05	0.000194	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DCN—uterine cancer	1.96e-05	0.000194	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—uterine cancer	1.95e-05	0.000192	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—STK11—uterine cancer	1.93e-05	0.00019	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.93e-05	0.00019	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.92e-05	0.000189	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.87e-05	0.000184	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.85e-05	0.000182	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.76e-05	0.000174	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.75e-05	0.000172	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.71e-05	0.000169	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STK11—uterine cancer	1.66e-05	0.000164	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP19A1—uterine cancer	1.66e-05	0.000164	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—EP300—uterine cancer	1.63e-05	0.000161	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POLD1—uterine cancer	1.6e-05	0.000158	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.56e-05	0.000154	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—uterine cancer	1.55e-05	0.000153	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—uterine cancer	1.54e-05	0.000152	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—uterine cancer	1.53e-05	0.000151	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—uterine cancer	1.52e-05	0.00015	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.5e-05	0.000148	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.49e-05	0.000147	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—uterine cancer	1.47e-05	0.000145	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—EP300—uterine cancer	1.47e-05	0.000145	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—uterine cancer	1.45e-05	0.000143	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—uterine cancer	1.45e-05	0.000143	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.37e-05	0.000135	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STK11—uterine cancer	1.37e-05	0.000135	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STK11—uterine cancer	1.36e-05	0.000134	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.36e-05	0.000134	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RRM2—uterine cancer	1.33e-05	0.000131	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—uterine cancer	1.33e-05	0.000131	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—uterine cancer	1.32e-05	0.00013	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DCN—uterine cancer	1.29e-05	0.000128	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.28e-05	0.000126	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—EP300—uterine cancer	1.27e-05	0.000125	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—uterine cancer	1.25e-05	0.000123	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—uterine cancer	1.24e-05	0.000122	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.22e-05	0.00012	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.22e-05	0.00012	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—uterine cancer	1.21e-05	0.000119	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—uterine cancer	1.2e-05	0.000119	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—uterine cancer	1.19e-05	0.000117	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—uterine cancer	1.17e-05	0.000115	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.15e-05	0.000114	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—uterine cancer	1.14e-05	0.000113	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—uterine cancer	1.12e-05	0.00011	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—uterine cancer	1.12e-05	0.00011	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.1e-05	0.000109	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—uterine cancer	1.09e-05	0.000107	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—uterine cancer	1.08e-05	0.000107	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—EP300—uterine cancer	1.06e-05	0.000105	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—EP300—uterine cancer	1.03e-05	0.000102	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000102	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—uterine cancer	1.02e-05	0.000101	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—uterine cancer	9.88e-06	9.74e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—uterine cancer	9.36e-06	9.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.01e-06	8.88e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STK11—uterine cancer	8.97e-06	8.85e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP19A1—uterine cancer	8.97e-06	8.85e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—uterine cancer	8.9e-06	8.78e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—uterine cancer	8.07e-06	7.96e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—uterine cancer	7.88e-06	7.76e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—EP300—uterine cancer	7.7e-06	7.59e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—uterine cancer	7.65e-06	7.54e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—uterine cancer	7.63e-06	7.53e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—uterine cancer	6.95e-06	6.85e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—uterine cancer	6.74e-06	6.65e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—EP300—uterine cancer	6.63e-06	6.53e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—uterine cancer	6.43e-06	6.34e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—uterine cancer	6.24e-06	6.15e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—uterine cancer	5.74e-06	5.66e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—uterine cancer	5.69e-06	5.61e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—uterine cancer	5.69e-06	5.61e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—EP300—uterine cancer	5.47e-06	5.4e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—EP300—uterine cancer	5.43e-06	5.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—uterine cancer	4.9e-06	4.83e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—uterine cancer	4.65e-06	4.59e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.05e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.01e-06	3.96e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—uterine cancer	4.01e-06	3.95e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—uterine cancer	3.75e-06	3.7e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—EP300—uterine cancer	3.58e-06	3.53e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—uterine cancer	3.31e-06	3.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—uterine cancer	3.28e-06	3.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.65e-06	2.61e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—uterine cancer	2.16e-06	2.13e-05	CbGpPWpGaD
